Abstract
The assessment of myocardial viability has become important in the diagnostic and prognostic work up of patients with ischemic cardiomyopathy. Patients with viable myocardium may benefit from revascularization in terms of improvement of function, symptoms, and prognosis. In contrast, patients without viable myocardium do not benefit and should be treated conservatively. Various nuclear imaging techniques are available.
MeSH terms
-
Animals
-
Cardiomyopathies / diagnostic imaging*
-
Cardiomyopathies / surgery
-
Diabetes Complications
-
Disease Models, Animal
-
Echocardiography, Stress*
-
Fluorodeoxyglucose F18
-
Heart / diagnostic imaging*
-
Humans
-
Myocardial Contraction*
-
Myocardial Ischemia / diagnostic imaging*
-
Myocardial Revascularization
-
Myocardial Stunning
-
Positron-Emission Tomography*
-
Prognosis
-
Radiopharmaceuticals
-
Retrospective Studies
-
Risk Factors
-
Sensitivity and Specificity
-
Stroke Volume
-
Swine
-
Tomography, Emission-Computed, Single-Photon*
-
Ventricular Dysfunction, Left
-
Ventricular Function, Left / physiology
Substances
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18